Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer-induced immunosuppression: implications for therapy?

R E Pollock1, J A Roth

  • 1University of Texas M.D. Anderson Cancer Center, Department of General Surgery, Houston 77030.

Seminars in Surgical Oncology
|January 1, 1989
PubMed
Summary

Cancer impairs the immune system through various factors, including surgical stress and tumor-produced transforming growth factor beta (TGF-beta). Understanding these mechanisms is key for effective cancer immunotherapy in surgical patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced telomeric signals and increased telomeric associations in human lung cancer cell lines undergoing p53-mediated apoptosis.

Oncogene·1998
Same author

Increased MHC class II and CD25 expression on lymphocytes in the absence of persistent lymphocytosis in cattle experimentally infected with bovine leukemia virus.

Veterinary immunology and immunopathology·1998
Same author

Effects of long-term infection with bovine immunodeficiency virus and/or bovine leukemia virus on antibody and lymphocyte proliferative responses in cattle.

Veterinary immunology and immunopathology·1998
Same author

Viral and nonviral gene delivery vectors for cancer gene therapy.

Cancer detection and prevention·1998
Same author

Immunology and prevention of infection in feedlot cattle.

The Veterinary clinics of North America. Food animal practice·1998
Same author

Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.

Seminars in oncology·1998

Area of Science:

  • Oncology
  • Immunology
  • Surgical Oncology

Background:

  • Cancer can induce immunosuppression through host- or tumor-derived factors.
  • Tumor presence can lead to host debility and immune anergy.
  • Antitumor treatments may negatively impact host antitumor immunity.

Purpose of the Study:

  • To identify key mechanisms of cancer-induced immunosuppression.
  • To highlight the role of surgical stress and TGF-beta in immune impairment.
  • To emphasize the importance of understanding these mechanisms for immunotherapy development in surgical oncology.

Main Methods:

  • Investigated factors contributing to cancer-induced immunosuppression.
  • Focused on surgical stress effects.
  • Examined tumor-mediated production of growth factors, specifically transforming growth factor beta (TGF-beta).

Related Experiment Videos

Main Results:

  • Surgical stress is implicated as a significant cause of host immune impairment.
  • Tumor-mediated production of transforming growth factor beta (TGF-beta) contributes to immune impairment.
  • These factors collectively impair the host's antitumor immunity.

Conclusions:

  • Surgical stress and tumor-derived TGF-beta are critical contributors to cancer-induced immunosuppression.
  • Understanding these mechanisms is essential for developing successful immunotherapy strategies.
  • This knowledge is particularly crucial for patients undergoing surgery for cancer.